Tuberculosis epidemics driven by HIV: is prevention better than cure?

被引:81
作者
Currie, CSM
Williams, BG
Cheng, RCH
Dye, C
机构
[1] World Hlth Org, Communicable Dis, Geneva, Switzerland
[2] Univ Southampton, Fac Math Studies, Southampton SO9 5NH, Hants, England
关键词
tuberculosis; HIV; epidemiology; mathematical modelling; Bayesian methods; antiretroviral therapy; DOTS; treatment of latent TB infection;
D O I
10.1097/00002030-200311210-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
objective: To compare the benefits of tuberculosis (TB) treatment with TB and HIV prevention for the control of TB in regions with high HIV prevalence. Design and methods: A compartmental difference equation model of TB and HIV has been developed and fitted to time series and other published data using Bayesian methods. The model is used to compare the effectiveness of TB chemotherapy with three strategies for prevention: highly active antiretroviral therapy (HAART), the treatment of latent TB infection (TLTI) and the reduction of HIV transmission. Results: Even where the prevalence of HIV infection is high, finding and curing active TB is the most effective way to minimize the number of TB cases and deaths over the next 10 years. HAART can be as effective, but only with very high levels of coverage and compliance. TLTI is comparatively ineffective over all time scales. Reducing HIV incidence is relatively ineffective in preventing TB and TB deaths over 10 years but is much more effective over 20 years. Conclusions: In countries where the spread of HIV has led to a substantial increase in the incidence of TB, TB control programmes should maintain a strong emphasis on the treatment of active TB. To ensure effective control of TB in the longer term, methods of TB prevention should be carried out in addition to, but not as a substitute for, treating active cases. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:2501 / 2508
页数:8
相关论文
共 29 条
[1]  
[Anonymous], 1979, Monte Carlo Methods, DOI DOI 10.1007/978-94-009-5819-7
[2]  
Badri M, 2002, INT J TUBERC LUNG D, V6, P231
[3]   SENSITIVITY AND UNCERTAINTY ANALYSIS OF COMPLEX-MODELS OF DISEASE TRANSMISSION - AN HIV MODEL, AS AN EXAMPLE [J].
BLOWER, SM ;
DOWLATABADI, H .
INTERNATIONAL STATISTICAL REVIEW, 1994, 62 (02) :229-243
[4]   Importance sampling: An illustrative introduction [J].
Borcherds, P.H. .
European Journal of Physics, 2000, 21 (05) :405-411
[5]  
*CASC COLL, 2001, LANCET, V355, P1131
[6]  
CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9
[7]  
COHN DL, 2000, LUNG BIOL HEALTH DIS, V144, P471
[8]   The growing burden of tuberculosis - Global trends and interactions with the HIV epidemic [J].
Corbett, EL ;
Watt, CJ ;
Walker, N ;
Maher, D ;
Williams, BG ;
Raviglione, MC ;
Dye, C .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (09) :1009-1021
[9]  
De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457
[10]   Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration [J].
Detels, R ;
Muñoz, A ;
McFarlane, G ;
Kingsley, LA ;
Margolick, JB ;
Giorgi, J ;
Scharager, LD ;
Phair, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17) :1497-1503